Hello all, First time posting, but I’ve been

Hello all,

First time posting, but I’ve been following this board for some time. Thank you all for your insight and invaluable knowledge and opinions.

I didn’t expect my first post to quite go like this but without further ado, I need some insight on the below post I copied from the CYDY Reddit board about our recent results. Seems reasonable to me but I’m not sure if I’m missing anything.

Posted by
u/Large-Waltz796
5 hours ago

I did the calculation with spreadsheet for all possibilities on critical patients.

The results are: the placebo has 19 patients, 2 survived with discharge alive but all others 17 dead at day 28, the death rate is 89.47%. The Leronlimab has 43 patients, 12 discharge alive at day 28, 26 dead, 5 still in hospital, the death rate is 60.47%. The death reduction is 23.53% by (17x2-26)/(17x2). If the 5 patients in hospital survived later, the death reduction is 89.47%-60.47%=29.01%.
This calculation meets total critical patients 62, 28% discharge alive in Leronlimab, 11% discharge alive in placebo, the death reduction of 24% at day 28.
The p value for critical patients is 0.0021 with a small sample size (62).
This result is not a full approval due to small sample size which will be fixed by OLE, but it is DEFINITELY an EUA at current point.
Update: Even all 5 patients in hospital at day 28 dead, the p value is 0.0451 still less than 0.05